Cardlytics, Inc. (CDLX) - Dilution Analysis

8-K filing: Stock split 1-for-10 | Outstanding: 54,896,000 → 5,807,863

10-Q filing | 54.9M shares outstanding

8-K filing: Cardlytics, Inc. completed the sale of its Bridg platform to PAR Technology Corporation on March 24, 2026, with PAR delivering 1,810,222 shares of PAR's common stock as consideration.

10-Q filing | 53.5M shares outstanding

10-Q filing | 52.8M shares outstanding

10-Q filing | 51.9M shares outstanding

10-K filing | 48.4M shares outstanding

10-Q filing | 50.0M shares outstanding

10-Q filing | 49.1M shares outstanding

10-Q filing | 48.8M shares outstanding

8-K filing: Cardlytics, Inc. completed a private offering of $172.5 million principal amount of 4.25% Convertible Senior Notes due 2029 and used approximately $169.3 million of the net proceeds, along with cash on hand, to repurchase approximately $183.9 million in aggregate principal amount of its 1.00% Convertible Senior Notes due 2025.

10-K filing | 44.1M shares outstanding

S-3/A filing: The company may offer and sell up to $100,000,000 of any combination of common stock, preferred stock, debt securities and warrants.

8-K filing: Cardlytics, Inc. entered into a settlement agreement with Shareholder Representative Services LLC to resolve disputes related to the Merger Agreement, agreeing to pay $25.0 million in cash and issue 3.6 million shares of Company common stock to SRS.

S-3 filing: The filing is an S-3 registration statement for the potential offering and sale of up to $100,000,000 of common stock, preferred stock, and/or debt securities.

10-Q filing | 39.3M shares outstanding

10-Q filing | 37.7M shares outstanding

10-Q filing | 33.7M shares outstanding

8-K filing: Cardlytics will pay $72,596,417 in cash and deliver 3,374,383 shares of its common stock to complete the First Anniversary Payment Amount related to the acquisition of Bridg, Inc. ($135.48M proceeds)

POS AM filing: This is a POS AM filing related to the potential offering of securities, including common stock, by the company or selling securityholders, through underwriters, dealers, or agents, with details to be provided in a prospectus supplement.

10-K filing | 33.6M shares outstanding

10-Q filing | 33.1M shares outstanding

10-Q filing | 33.0M shares outstanding

10-Q filing | 34.1M shares outstanding

10-K filing | 33.7M shares outstanding

10-Q filing | 33.3M shares outstanding

10-Q filing | 33.0M shares outstanding

10-Q filing | 32.9M shares outstanding

8-K filing: Cardlytics, Inc. completed an offering of 3,850,000 shares of its common stock at a price of $130.00 per share, resulting in net proceeds of approximately $483.7 million to the company. ($483.7M proceeds)

8-K filing: The Company entered into a Merger Agreement with DOSH Holdings, Inc. to acquire Dosh for $275.0 million, consisting of $150.0 million in cash and $125.0 million of the Company's common stock at $136.33 per share. ($125.0M proceeds)

10-K filing | 27.9M shares outstanding

10-Q filing | 27.5M shares outstanding

10-Q filing | 22.5M shares outstanding

10-Q filing | 22.5M shares outstanding

10-K filing | 26.7M shares outstanding